| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Conversion from cyclosporine to tacrolimus in renal transplant recipients with gum hyperplasia
|
Kohnle, M
|
|
1999
|
|
7S1 |
p. 44-45
2 p.
|
artikel
|
| 2 |
Conversion to tacrolimus for acute corticosteroid- and antibody-resistant rejection following kidney transplantation
|
Kliem, V
|
|
1999
|
|
7S1 |
p. 37-40
4 p.
|
artikel
|
| 3 |
Conversion to tacrolimus in hyperlipidemic patients
|
Friemann, S
|
|
1999
|
|
7S1 |
p. 41-43
3 p.
|
artikel
|
| 4 |
Corticosteroid withdrawal under tacrolimus primary and rescue therapy in renal transplantation: the Chicago experience
|
Woodle, E.S
|
|
1999
|
|
7S1 |
p. 84-85
2 p.
|
artikel
|
| 5 |
Dosing and management guidelines for tacrolimus in renal transplant patients
|
van Hooff, J.P
|
|
1999
|
|
7S1 |
p. 54-57
4 p.
|
artikel
|
| 6 |
Editorial
|
|
|
1999
|
|
7S1 |
p. 1-
1 p.
|
artikel
|
| 7 |
Effect of immunosuppressive therapy on graft half-life projections
|
Opelz, G
|
|
1999
|
|
7S1 |
p. 31-33
3 p.
|
artikel
|
| 8 |
Four-year follow-up of the European Tacrolimus Multicenter Renal Study
|
Mayer, A.D
|
|
1999
|
|
7S1 |
p. 27-28
2 p.
|
artikel
|
| 9 |
Immunological and nonimmunological risk factors with tacrolimus and Neoral in renal transplant recipients: an interim report
|
Jurewicz, W.A
|
|
1999
|
|
7S1 |
p. 64-66
3 p.
|
artikel
|
| 10 |
Induction therapy with rabbit antithymocyte sera reduces rejection episodes in immunologically low-risk living donor renal transplant recipients
|
Cardella, C.J.
|
|
1997
|
|
7S1 |
p. 29S-31S
nvt p.
|
artikel
|
| 11 |
Lymphocyte subsets during and after rabbit anti-thymocyte globulin induction in pediatric renal transplantation: Sustained T cell depletion
|
Bell, L.
|
|
1997
|
|
7S1 |
p. 6S-9S
nvt p.
|
artikel
|
| 12 |
Mechanisms of chronic rejection
|
Häyry, P
|
|
1999
|
|
7S1 |
p. 5-8
4 p.
|
artikel
|
| 13 |
Multi-organ experience with RATG/RATS in North America from 1989 to 1996
|
Guttmann, Ronald D.
|
|
1997
|
|
7S1 |
p. 5S-
1 p.
|
artikel
|
| 14 |
Outcome of tacrolimus conversion therapy for renal allograft rejection: 5-year follow-up
|
Jordan, M.L
|
|
1999
|
|
7S1 |
p. 81-83
3 p.
|
artikel
|
| 15 |
Pancreas transplantation with ATG vs OKT3
|
Rosenberg, L.
|
|
1997
|
|
7S1 |
p. 35S-36S
nvt p.
|
artikel
|
| 16 |
Pharmacokinetics, foreign protein immune response, cytokine release, and lymphocyte subsets in patients receiving thymoglobuline and immunosuppression
|
Guttmann, R.D.
|
|
1997
|
|
7S1 |
p. 24S-26S
nvt p.
|
artikel
|
| 17 |
Pharmacokinetics of tacrolimus: clinically relevant aspects
|
Undre, N.A
|
|
1999
|
|
7S1 |
p. 21-24
4 p.
|
artikel
|
| 18 |
Report of the first 118 tacrolimus-treated patients at St George’s Hospital, London
|
Oliveira, D.B.G
|
|
1999
|
|
7S1 |
p. 61-63
3 p.
|
artikel
|
| 19 |
Risk-benefit of OKT3 prophylaxis in immunologic high-risk cadaver kidney transplant recipients
|
Cogny-Van Weydevelt, F.
|
|
1997
|
|
7S1 |
p. 32S-34S
nvt p.
|
artikel
|
| 20 |
Seven-year experience with rabbit antithymocyte globulin after cardiac transplantation at the Montreal Heart Institute
|
Beaufigeau, M.
|
|
1997
|
|
7S1 |
p. 10S-12S
nvt p.
|
artikel
|
| 21 |
Single-center experience with initial intravenous dosing of tacrolimus after kidney transplantation
|
Soriano, S
|
|
1999
|
|
7S1 |
p. 51-53
3 p.
|
artikel
|
| 22 |
Single center experience with thymoglobulin in renal transplantation
|
Zaltzman, J.S.
|
|
1997
|
|
7S1 |
p. 27S-28S
nvt p.
|
artikel
|
| 23 |
Tacrolimus and glucose metabolism
|
van Hooff, J.P
|
|
1999
|
|
7S1 |
p. 49-50
2 p.
|
artikel
|
| 24 |
Tacrolimus and mycophenolate mofetil in cadaveric renal transplant recipients
|
Forsythe, J
|
|
1999
|
|
7S1 |
p. 69-71
3 p.
|
artikel
|
| 25 |
Tacrolimus-based immunosuppression in pediatric renal transplantation
|
Jordan, M.L
|
|
1999
|
|
7S1 |
p. 29-30
2 p.
|
artikel
|
| 26 |
Tacrolimus, mycophenolate mofetil and corticosteroids as primary immunosuppression after renal transplantation at the Hospital 12 De Octubre, Madrid
|
Morales, J.M
|
|
1999
|
|
7S1 |
p. 75-77
3 p.
|
artikel
|
| 27 |
The Benelux experience with the combination of tacrolimus and mycophenolate mofetil
|
Squifflet, J.P
|
|
1999
|
|
7S1 |
p. 72-74
3 p.
|
artikel
|
| 28 |
The effects of lipids on graft outcome
|
Fellström, B
|
|
1999
|
|
7S1 |
p. 14-15
2 p.
|
artikel
|
| 29 |
The future of new immunosuppressive drugs
|
Paul, L.C
|
|
1999
|
|
7S1 |
p. 16-18
3 p.
|
artikel
|
| 30 |
The role of transforming growth factor-β in transplant rejection
|
Hutchinson, I.V
|
|
1999
|
|
7S1 |
p. 9-13
5 p.
|
artikel
|
| 31 |
The US compassionate experience with thymoglobulin for the treatment of resistant acute rejection
|
Daoud, A.J.
|
|
1997
|
|
7S1 |
p. 18S-20S
nvt p.
|
artikel
|
| 32 |
Thymoglobulin reverses acute renal allograft rejection better than ATGAM—A double-blinded randomized clinical trial
|
Tesi, R.J.
|
|
1997
|
|
7S1 |
p. 21S-23S
nvt p.
|
artikel
|
| 33 |
Use of rabbit anti-thymocyte globulin for induction immunosuppression in high-risk kidney transplant recipients
|
Belitsky, P.
|
|
1997
|
|
7S1 |
p. 16S-17S
nvt p.
|
artikel
|
| 34 |
Use of thymoglobulin induction therapy in the prevention of acute graft rejection episodes following liver transplantation
|
Tchervenkov, J.
|
|
1997
|
|
7S1 |
p. 13S-15S
nvt p.
|
artikel
|
| 35 |
Vascular rejection with tacrolimus and potential long-term graft outcome
|
Vanrenterghem, Y
|
|
1999
|
|
7S1 |
p. 86-87
2 p.
|
artikel
|
Tijdschrift beschrijving